Risedronate

Risedronate sodium (Actonel®) is a bisphosphonate used to strengthen bone, treat or prevent osteoporosis, and treat Paget's disease of bone. It is produced and marketed by Procter & Gamble and Sanofi-Aventis.

Administration

Risedronate is taken orally, usually 5 mg daily or 35 mg weekly. Notably, if risedronate lodges in the oesophagus, it can lead to oesophageal ulcers. Therefore, it is recommended that risedronate be taken with the body upright, and followed by a glass of water.

Risedronate is poorly absorbed when taken with food, so it is recommended that no food or drink other than water be taken for 2 hours before and 30 minutes after taking risedronate. Risedronate has a faster oesophageal transit time and different chemical chain which results in less gastrointestinal side-effects than other drugs in this class.

The dosage instructions also show that risedronate can be taken with less water than other drugs in the class.

In common with other bisphosphonate drugs, risedronate appears to be associated with the rare side effect osteonecrosis of the jaw, often preceded by a dental procedures.

© Medic8 ® All Rights Reserved.